Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laporte was a prominent British specialty chemical company that played a significant role in the pharmaceutical supply chain through its fine chemicals division. Founded in 1888, the company evolved from a manufacturer of hydrogen peroxide into a global provider of sophisticated chemical intermediates and active pharmaceutical ingredients (APIs). At its peak, Laporte operated numerous subsidiaries focused on high-growth sectors including healthcare, electronics, and catalysts. The company was acquired by the German chemical group Degussa in 2001, which subsequently became part of Evonik Industries. Today, its legacy pharmaceutical manufacturing assets continue to operate under various corporate umbrellas within the global life sciences sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laporte.